Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,508.5
-63.4 (-2.46%)

 

  • STI Straits Times Index
    2,508.5
    -63.4 (-2.46%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,362.2
    -7.7 (-0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,070.7
    -182.6 (-0.75%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,806.0
    -14.8 (-0.52%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    18,981.1
    30.9 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,778.6
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 230.7M
  • Value: 242.4M
  • Rise: 39
  • Fall: 165
  • Unch: 608

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.105-0.004
ESR-REIT0.250-0.015
IPS Securex0.060-0.001
MDR0.001-
Genting Sing0.715-0.010
Medtecs Intl0.102+0.003
Singtel2.650-0.020
AusGroup^0.023-0.001
CapitaMall Trust1.670-0.070
Suntec Reit1.190-0.050

World Indices

World Indices
Name Last Change
Nasdaq 7,887.3 -26.0
HSI 24,023.5 -229.8
HSCEI 9,749.2 -97.7
Jakarta 4,685.6 -93.0
Nikkei 225 18,990.0 +39.8
SSE Comp 2,805.4 -15.3
Shanghai A 2,940.1 -16.1
Shanghai B 218.7 -0.9
KOSPI 1,816.4 -7.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SIERRA ONCOLOGY INC SIERRA ONCOLOGY INC
Updated on 07 Apr 2020 (End of trading day)
Last (USD): 9.010 Change: +0.130 High: 9.500 Remarks: -
Change (%): +1.46 Low: 9.010
Open 9.280 Yesterday's Close 8.879999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 7,996 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -5.13049 Trailing EPS (USD) e -8.49149 NAV (USD) b 8.3057
PE a - Trailing PE f - Price / NAV b 1.0848
Dividend (USD) d - Cash In Hand (USD) g 14.1913 Issued & Paid-up Shares c 10,395,700
Dividend Yield (%) d - Price / Cash In Hand g 0.635 Treasury Shares h -
Beta - 75 Daysi 1.043 R-Squared - 75 Days(%)i 0.02 Market Cap (M) 93.665
Beta - 500 Daysi 0.943 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) -53.301
Piotroski F Score 0 Exchange Code SRRA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 110.36 Free Float (%) 70.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jan 2017.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SIERRA ONCOLOGY INC NASDAQ 93.665 - - 1.0848 -
Industry Biotechnology NASDAQ 2,356.981 269.844 255.795 5.6458 0.774
Local Peer AMGEN INC NASDAQ 123,139.905 14.670 15.703 12.7303 2.700
Local Peer GILEAD SCIENCES INC NASDAQ 94,010.277 17.234 17.455 4.1736 3.109
Local Peer VERTEX PHARMACEUTICAL NASDAQ 64,213.153 30.630 54.565 10.5523 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,176.115 22.572 26.078 4.9754 -
Local Peer BIOGEN INC NASDAQ 52,429.817 11.833 8.904 3.9293 -
Local Peer ILLUMINA INC NASDAQ 41,254.080 49.944 41.172 8.9430 -
Local Peer SEATTLE GENETICS INC NASDAQ 20,993.326 - - 11.1887 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 21,037.312 271.101 8.750 1.8664 -
Local Peer INCYTE CORPORATION NASDAQ 18,785.808 171.570 42.035 7.2297 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,363.493 - - 4.6002 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 12,592.387 - 40.574 4.5559 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 12,383.645 - - 8.6076 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ALKERMES PLC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ALECTOR INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), INSMED INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), EDITAS MEDICINE INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), REGENXBIO INC (NASDAQ), VERACYTE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), OMEROS CORP (NASDAQ), CYTOKINETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), ARDELYX INC (NASDAQ), PRECIGEN INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), VERASTEM INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AGENUS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), XBIOTECH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), KAMADA (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADURO BIOTECH INC (NASDAQ), GERON CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), MANNKIND CORPORATION (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CABALETTA BIO INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), MEDICINOVA INC (NASDAQ), INFLARX N V (NASDAQ), AFFIMED N V (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ARAVIVE INC (NASDAQ), IMV INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VERMILLION INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), VACCINEX INC (NASDAQ), OTONOMY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), COHBAR INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ADVAXIS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SOLIGENIX INC (NASDAQ), INMUNE BIO INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), EVOGENE LTD (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), BIOCARDIA INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OCUGEN INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), PRECIPIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ)
Global Peer CSL ASX 141,658.748 52.800 48.902 16.3797 0.850
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 22,923.464 72.543 30.005 4.7284 0.827
Global Peer WUXI BIO HKEx 148,320.804 198.581 129.214 10.3717 -
Global Peer SINO BIOPHARM HKEx 136,872.304 12.774 44.467 3.9329 0.672
Global Peer BEIGENE HKEx 82,446.080 - - 10.9968 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,077.360 49.081 56.362 2.8272 -
Global Peer GENSCRIPT BIO HKEx 23,694.260 142.494 - 7.9438 -
Global Peer 3SBIO HKEx 21,500.926 14.213 19.586 1.9970 -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), UNI-BIO GROUP (HKEx), NEXT SCIENCE LTD (ASX), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIOTRON (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), ORAGENICS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ANTEOTECH LIMITED (ASX), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), Suntar Eco-City^ (SGX), ACTINIUM PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), HAO WEN HLDGS (HKEx), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), BENITEC BIOPHARMA LTD (ASX), LEAF RESOURCES LTD (ASX), ADALTA LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.810
-8.25 %
10 Days --0.620
-6.44 %
20 Days --3.020
-25.10 %
Medium Term Return 3 Months --6.290
-41.11 %
6 Months --3.746
-29.37 %
1 Year --51.790
-85.18 %
Long Term Return 2 Years --72.190
-88.90 %
3 Years --47.390
-84.02 %
Annualised Return Annualised --
-45.74 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.545 - 65.660 Change From 1 Year Low +0.465 % Change From 1 Year Low (%) +5.44
Change From 1 Year High -56.650 % Change From 1 Year High (%) -86.28
2 Years Range 8.545 - 148.000 Change From 2 Years Low +0.465 % Change From 2 Years Low (%) +5.44
Change From 2 Years High -138.990 % Change From 2 Years High (%) -93.91
5 Years Range 8.545 - 163.600 Change From 5 Years Low +0.465 % Change From 5 Years Low (%) +5.44
Change From 5 Years High -154.590 % Change From 5 Years High (%) -94.49
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
06 Apr 2020 9.560 9.649 8.880 8.880 15,625 -
03 Apr 2020 9.000 9.140 8.650 8.990 13,484 -
02 Apr 2020 8.801 9.960 8.801 9.060 6,364 -
01 Apr 2020 9.730 10.000 8.780 9.030 20,478 -
31 Mar 2020 9.950 10.530 9.770 9.820 15,632 -
30 Mar 2020 9.990 10.441 9.900 9.960 19,566 -
27 Mar 2020 10.230 10.861 9.668 10.270 24,623 -
26 Mar 2020 9.500 11.270 9.500 10.490 64,368 -
25 Mar 2020 9.500 10.633 8.950 9.630 23,280 -
24 Mar 2020 10.150 10.284 9.320 9.630 16,042 -
23 Mar 2020 9.402 9.970 8.997 9.780 8,722 -
20 Mar 2020 9.750 10.140 9.090 9.380 23,049 -
19 Mar 2020 9.070 10.150 8.558 9.600 15,811 -
18 Mar 2020 9.330 9.540 8.545 9.510 27,121 -
17 Mar 2020 9.680 9.680 9.030 9.500 28,311 -
16 Mar 2020 8.750 9.750 8.700 9.490 49,988 -
13 Mar 2020 8.960 9.490 8.900 9.240 37,293 -
12 Mar 2020 11.000 11.280 9.000 9.040 56,368 -
11 Mar 2020 12.030 12.200 11.150 11.600 32,735 -
10 Mar 2020 12.390 12.770 11.886 12.030 53,455 -
09 Mar 2020 12.360 12.360 11.900 12.320 37,077 -
06 Mar 2020 11.910 13.450 11.821 12.850 36,565 -
Summary
Current 2 Weeks
(24 Mar 2020 to 06 Apr 2020)
10.150 11.270 8.650 8.880 219,462 -
Previous 2 Weeks
(10 Mar 2020 to 23 Mar 2020)
12.390 12.770 8.650 9.780 332,853 -
4 Weeks from
(10 Feb 2020 to 09 Mar 2020)
12.800 13.185 8.650 12.320 1,027,270 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.